fda warning letters compounded semaglutide tirzepatide 2025 Compound versions of GLP-1 drugs for weight loss halted by FDA Issues Warning Letters to

Follow your doctor's instructions about any restrictions on food, beverages, or activity

Obesity brings increased risk for other diseases such as diabetes, heart disease, cancer, or even stroke

Most yeast infections can be managed without emergency care

If you are currently using Wegovy and find out that youre pregnant, speak with your healthcare provider and explain that you are pregnant so that they can weigh the risks and benefits of continuing treatment with Wegovy or switching to a different medication or treatment course

Key Takeaways Weight loss plateaus on Semaglutide are a normal metabolic adaptation, typically occurring between 20 and 60 weeks of treatment

This temporary tinnitus generally resolves after discontinuing the medication in question